Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
Narat Srivali, Assistant Professor at Duke University Medical Center, shared on LinkedIn about a recent article he and Federica De Giacomi co-authored, published in Expert Opinion on Pharmacotherapy, adding:
”Excited to share our new systematic review and meta-analysis on glucocorticoid therapy and the risk of venous thromboembolism (VTE).
We found that glucocorticoid use is associated with an approximately 2.6-fold increased risk of VTE, with the highest risk seen early in treatment, at higher doses, and with systemic formulations.
These findings may help clinicians think more carefully about VTE risk stratification when initiating glucocorticoids, especially in patients with additional risk factors.”
Title: Glucocorticoid therapy and risk of venous thromboembolism: a systematic review and meta-analysis with exploration of dose, duration, and route-specific effects
Authors: Narat Srivali, Federica De Giacomi
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
-
May 22, 2026, 08:35Jason Brandon: On Lyophilized Hemostatic Supplementation at Simmons Research Day 2026